Table 5.
Procedure | Test | Strengths | Limitations | MSMD defect detected (published) |
---|---|---|---|---|
Culture and cytokine determination | Basal IFN-γ in plasma | Easy and cheap to perform, when established, high levels of IFN-γ are indicative of IFN-γ receptor defect | Differences between kits, normalization of IFN-γ levels after acute phase of the infection | AR IFN-γ receptors defects |
WB culture with BCG stimulation | Most similar condition to reality | Partial defects can be occult, some MSMD defects have normal results; big variability in healthy controls, use of BCG difficult a lot ISO regulations acceptance Needs to be performed in fresh blood (max. 48h after extraction) |
AR IFN-γ receptors, IL-12Rβ1, IL-12p40, ISG15/TYK2 defects | |
PBMCs culture with BCG stimulation | Can be performed in cryopreserved cells | Partial defects can be occult, some MSMD defects have normal results; big variability in healthy controls, use of BCG difficult a lot ISO regulations acceptance | ||
WB culture with mitogen stimulation | NO use of BCG | Mycobacterial-specific immunity is not tested Needs to be performed in fresh blood (max. 48h after extraction) |
AR IFN-γR1, IL-12Rβ1, IL-12p40 defects NEMO deficiency performed in PBMCs |
|
PBMCs culture with mitogen stimulation | NO use of BCG. Can be performed in cryopreserved cells |
Mycobacterial-specific immunity is not tested | ||
Cytometry (in primary cells) | IFN-γ binding | Useful to detect defects in IFN-γR1 when it is expressed in the membrane | There are some defects that bind IFN-γ but have no functional IFN-γR1 | IFN-γR1 defects |
IFN-γR1 determination | Easy to perform, rapid diagnosis of some forms of IFN-γR1deficiency. | Some forms of IFN-γR1 deficiency present a non-functional form of IFN-γR1 in the membrane, so presence of the receptor does not exclude the defect. | IFN-γR1 defects | |
IFN-γR2 determination | Easy to perform, rapid diagnosis of some forms of IFNGR2 deficiency | Some forms of IFNGR2 present a non-functional form of IFN-γR2 in the membrane, so presence of the receptor does not exclude the defect. | IFN-γR2 defects | |
STAT1 phosphorylation determination | Rapid test that evaluates the function of both IFN-γR1/IFN-γR2 and can detect some forms of STAT1 deficiency | Partial forms of IFN-γ R1/2 defects can be occult if only high levels of IFN-γ are used, some STAT1 defects present normal STAT1 phosphorylation after IFN-γ stimulation | IFN-γR1/2 defects, STAT1, TYK2 (help) | |
IL-12Rβ1 determination | Rapid/easy test; all but one mutation in IL12Rβ1 present a lack of IL-12Rβ1 in the membrane. | There is a form of IL-12Rβ1 defect that present IL-12Rβ1 in the membrane of act lymphocytes, so it’s present does not exclude the defect | IL-12Rβ1 defects | |
STAT4 determination | Evaluates both IL-12Rβ1 and Tyk2 function. | Long technique; no STAT4 antibody to detect total STAT4. | IL-12Rβ1, TYK2 defects | |
Genetics | Sanger | When the number of candidate genes is small, it can be easy, rapid and cheap. Easy to analyze and interpret | Slow and expensive if there is not a clear orientation of the defect. Not useful for the discovery of new genes. | All known defects |
Next generation sequencing | Indicated when there is no clear candidate gene, study of all known defects at once | Expensive, difficult to analyze and interpret results due to the huge amount of generated data. Especially with whole genome sequencing, gene panels are more affordable and easy to interpret. | All known defects, discovery of new genes or new manifestations of known genes | |
Useful for new genes discovery; detection of mutations in non-coding/regulatory regions with whole genome sequencing (not whole exome sequencing) |
PBMC: peripheral mononuclear cells; WB: whole blood.